Vicarious Surgical
RBOT
RBOT was delisted on the 2nd of March, 2026.
61 hedge funds and large institutions have $171M invested in Vicarious Surgical in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 9 closing their positions.
1,008% more call options, than puts
Call options by funds: $13.9M | Put options by funds: $1.26M
111% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 9
55% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 11
15% more funds holding
Funds holding: 53 → 61 (+8)
0% less ownership
Funds ownership: 1.13% → 1.13% (-0%)
58% less capital invested
Capital invested by funds: $406M → $171M (-$235M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DP
DDD Partners
Bellevue,
Washington
|
+$4.9M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
+$757K |
| 4 |
State Street
Boston,
Massachusetts
|
+$712K |
| 5 |
Millennium Management
New York
|
+$593K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIC
Chase Investment Counsel
Charlottesville,
Virginia
|
-$383K |
| 2 |
MAM
Maytree Asset Management
Hong Kong
|
-$371K |
| 3 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$346K |
| 4 |
BlackRock
New York
|
-$178K |
| 5 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
-$167K |
RBOT Hedge Fund Activity: Q1 2022 in Review
61 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q1 2022, worth a combined $171M — down 58% from $406M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new RBOT positions and 9 closed out — a net gain of 10 holders — while 17 added to existing stakes and 11 trimmed.
The largest buyer was DDD Partners, adding an estimated $4.9M. The largest seller was Chase Investment Counsel, exiting entirely with an estimated $383K sold.
- 61 institutional investors held Vicarious Surgical (RBOT) as of Q1 2022, up from 53 in Q4 2021.
- Funds reported $171M of Vicarious Surgical stock for Q1 2022, down 58% quarter-over-quarter.
- 19 funds opened new Vicarious Surgical positions in Q1 2022 and 9 closed out, a net change of +10 holders.
- The largest Vicarious Surgical buyer in Q1 2022 was DDD Partners, an estimated $4.9M added.
- The largest Vicarious Surgical seller in Q1 2022 was Chase Investment Counsel, an estimated $383K sold.
Based on aggregated 13F filings for Q1 2022.